Search research articles
Contact Us
Filters
Showing results (11-20 of 327) with videos related to
Page
of 33
Sort By:
Expert Opinion on Drug Safety
|
July 29, 2016
Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Acta Ophthalmologica
|
September 28, 2019
Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis
Ana Penedones, Carlos Alves, Francisco Batel Marques
Journal of Nursing Management
|
April 24, 2014
Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports
Diogo Mendes, Carlos Alves, Francisco Batel Marques
BMC Medical Research Methodology
|
December 13, 2019
Recommendations to conduct and report systematic reviews in medical literature: a scoping review
Ana Penedones, Carlos Alves, Francisco Batel-Marques
CNS Drugs
|
August 20, 2016
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
Diogo Mendes, Carlos Alves, Francisco Batel-Marques
Pharmacoepidemiology and Drug Safety
|
October 26, 2011
Data sources on drug safety evaluation: a review of recent published meta-analyses
Carlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
Diabetes Research and Clinical Practice
|
September 27, 2012
A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer
Carlos Alves, Francisco Batel-Marques, Ana F Macedo
Journal of Clinical Medicine
|
January 28, 2026
Quality of Systematic Reviews with Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Bruna Ramalho, Ana Penedones, Diogo Mendes, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 12, 2026
Clinical outcomes in HTA appraisal reports of oncology medicines in Portugal: A cross-sectional analysis
Pedro Teodoro, Catarina Ribeiro, Diogo Mendes, et al.
European Journal of Clinical Pharmacology
|
April 3, 2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier
Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo
Page
of 33
Search research articles
Search
Showing results (11-20 of 327) with videos related to
Sort By:
Page
of 33
Expert Opinion on Drug Safety
|
July 29, 2016
Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Acta Ophthalmologica
|
September 28, 2019
Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis
Ana Penedones, Carlos Alves, Francisco Batel Marques
Journal of Nursing Management
|
April 24, 2014
Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports
Diogo Mendes, Carlos Alves, Francisco Batel Marques
BMC Medical Research Methodology
|
December 13, 2019
Recommendations to conduct and report systematic reviews in medical literature: a scoping review
Ana Penedones, Carlos Alves, Francisco Batel-Marques
CNS Drugs
|
August 20, 2016
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
Diogo Mendes, Carlos Alves, Francisco Batel-Marques
Pharmacoepidemiology and Drug Safety
|
October 26, 2011
Data sources on drug safety evaluation: a review of recent published meta-analyses
Carlos Alves, Francisco Batel-Marques, Ana Filipa Macedo
Diabetes Research and Clinical Practice
|
September 27, 2012
A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer
Carlos Alves, Francisco Batel-Marques, Ana F Macedo
Journal of Clinical Medicine
|
January 28, 2026
Quality of Systematic Reviews with Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Bruna Ramalho, Ana Penedones, Diogo Mendes, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
May 12, 2026
Clinical outcomes in HTA appraisal reports of oncology medicines in Portugal: A cross-sectional analysis
Pedro Teodoro, Catarina Ribeiro, Diogo Mendes, et al.
European Journal of Clinical Pharmacology
|
April 3, 2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier
Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo
Page
of 33